These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1916007)
21. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. Gatti G; Barzaghi N; Acuto G; Abbiati G; Fossati T; Perucca E Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):331-5. PubMed ID: 1428296 [TBL] [Abstract][Full Text] [Related]
22. [Use of reminyl (galantamine) in the treatment of dementia]. Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Napryeyenko O; Sonnik G; Tartakovsky I J Neurol Sci; 2009 Aug; 283(1-2):224-9. PubMed ID: 19286192 [TBL] [Abstract][Full Text] [Related]
24. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981 [TBL] [Abstract][Full Text] [Related]
25. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study. Görtelmeyer R; Erbler H Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054 [TBL] [Abstract][Full Text] [Related]
26. Revisiting choline alphoscerate profile: a new, perspective, role in dementia? Scapicchio PL Int J Neurosci; 2013 Jul; 123(7):444-9. PubMed ID: 23387341 [TBL] [Abstract][Full Text] [Related]
28. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911 [TBL] [Abstract][Full Text] [Related]
29. CDP-choline and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves. Aslan E; Kocaeli H; Bekar A; Tolunay S; Ulus IH Neurol Res; 2011 Sep; 33(7):766-73. PubMed ID: 21756558 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Tariot PN; Erb R; Podgorski CA; Cox C; Patel S; Jakimovich L; Irvine C Am J Psychiatry; 1998 Jan; 155(1):54-61. PubMed ID: 9433339 [TBL] [Abstract][Full Text] [Related]
31. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results. Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283 [TBL] [Abstract][Full Text] [Related]
32. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey. Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121 [TBL] [Abstract][Full Text] [Related]
33. Performance on the Hooper Visual Organizational Test in patients diagnosed with subcortical vascular dementia: relation to naming performance. Paul R; Cohen R; Moser D; Ott B; Zawacki T; Gordon N Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):93-7. PubMed ID: 11417672 [TBL] [Abstract][Full Text] [Related]
34. The long-term efficacy and tolerability of donepezil in patients with vascular dementia. Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601 [TBL] [Abstract][Full Text] [Related]
35. [CDP-choline improves the postoperative rehabilitation of patients with cerebral risk]. Bricourt MO; Ghnassia MD; Legout-Montdargent V Agressologie; 1990; 31(7):457-63. PubMed ID: 2088110 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases. Lozano Fernández R Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470 [TBL] [Abstract][Full Text] [Related]
37. [Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome]. Gavrilova SI; Fedorova IaB; Gantman ; Kalyn IaB; Kolykhalov IV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):16-20. PubMed ID: 22433803 [TBL] [Abstract][Full Text] [Related]
38. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders]. Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953 [TBL] [Abstract][Full Text] [Related]
39. CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. Cetinkaya M; Cansev M; Cekmez F; Tayman C; Canpolat FE; Kafa IM; Uysal S; Tunc T; Sarici SU J Surg Res; 2013 Jul; 183(1):119-28. PubMed ID: 23228325 [TBL] [Abstract][Full Text] [Related]
40. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin. Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]